MDxHealth SA (MDXH) Tops Q2 EPS

MDxHealth SA (NASDAQ: MDXH) reported Q2 EPS of ($0.12), $0.45 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $6.41 million.

GUIDANCE:

MDxHealth SA sees Q3 2022 revenue of $40-42 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group